nodes	percent_of_prediction	percent_of_DWPC	metapath
Antipyrine—Clobazam—epilepsy syndrome	0.335	1	CrCtD
Antipyrine—CYP2C19—epilepsy syndrome	0.0482	0.423	CbGaD
Antipyrine—CYP2D6—epilepsy syndrome	0.0357	0.314	CbGaD
Antipyrine—PTGS2—epilepsy syndrome	0.03	0.263	CbGaD
Antipyrine—Methylphenobarbital—Primidone—epilepsy syndrome	0.0279	0.109	CrCrCtD
Antipyrine—Methsuximide—Primidone—epilepsy syndrome	0.0279	0.109	CrCrCtD
Antipyrine—Methylphenobarbital—Fosphenytoin—epilepsy syndrome	0.0279	0.109	CrCrCtD
Antipyrine—Phensuximide—Primidone—epilepsy syndrome	0.0261	0.102	CrCrCtD
Antipyrine—Methsuximide—Phenobarbital—epilepsy syndrome	0.0206	0.0805	CrCrCtD
Antipyrine—Methylphenobarbital—Phenobarbital—epilepsy syndrome	0.0206	0.0805	CrCrCtD
Antipyrine—Methsuximide—Phenytoin—epilepsy syndrome	0.0191	0.0748	CrCrCtD
Antipyrine—Methylphenobarbital—Phenytoin—epilepsy syndrome	0.0191	0.0748	CrCrCtD
Antipyrine—Methsuximide—Clobazam—epilepsy syndrome	0.0156	0.061	CrCrCtD
Antipyrine—Phensuximide—Clobazam—epilepsy syndrome	0.0146	0.0572	CrCrCtD
Antipyrine—CYP2C18—Clobazam—epilepsy syndrome	0.0136	0.0534	CbGbCtD
Antipyrine—Phensuximide—Diazepam—epilepsy syndrome	0.0136	0.0532	CrCrCtD
Antipyrine—CYP2C18—Phenytoin—epilepsy syndrome	0.0101	0.0397	CbGbCtD
Antipyrine—CYP2C18—Propofol—epilepsy syndrome	0.00943	0.037	CbGbCtD
Antipyrine—CYP2C18—Phenobarbital—epilepsy syndrome	0.00902	0.0353	CbGbCtD
Antipyrine—CYP2C18—Diazepam—epilepsy syndrome	0.00855	0.0335	CbGbCtD
Antipyrine—Clobazam—Midazolam—epilepsy syndrome	0.00781	0.0306	CrCrCtD
Antipyrine—Clobazam—Oxcarbazepine—epilepsy syndrome	0.00781	0.0306	CrCrCtD
Antipyrine—Clobazam—Diazepam—epilepsy syndrome	0.00696	0.0272	CrCrCtD
Antipyrine—CYP2C18—Valproic Acid—epilepsy syndrome	0.00674	0.0264	CbGbCtD
Antipyrine—CYP2A6—Amobarbital—epilepsy syndrome	0.00615	0.0241	CbGbCtD
Antipyrine—CYP2E1—Felbamate—epilepsy syndrome	0.00535	0.021	CbGbCtD
Antipyrine—CYP2E1—Trimethadione—epilepsy syndrome	0.00535	0.021	CbGbCtD
Antipyrine—CYP2B6—Fosphenytoin—epilepsy syndrome	0.00497	0.0195	CbGbCtD
Antipyrine—TRPA1—vagus nerve—epilepsy syndrome	0.00495	0.417	CbGeAlD
Antipyrine—CYP2A6—Propofol—epilepsy syndrome	0.00458	0.018	CbGbCtD
Antipyrine—CYP2E1—Clonazepam—epilepsy syndrome	0.00455	0.0178	CbGbCtD
Antipyrine—CYP2A6—Phenobarbital—epilepsy syndrome	0.00438	0.0172	CbGbCtD
Antipyrine—CYP2B6—Clobazam—epilepsy syndrome	0.00431	0.0169	CbGbCtD
Antipyrine—CYP2C8—Trimethadione—epilepsy syndrome	0.004	0.0157	CbGbCtD
Antipyrine—CYP2C8—Fosphenytoin—epilepsy syndrome	0.00376	0.0147	CbGbCtD
Antipyrine—CYP2E1—Rufinamide—epilepsy syndrome	0.00371	0.0146	CbGbCtD
Antipyrine—CYP2C19—Oxcarbazepine—epilepsy syndrome	0.00361	0.0142	CbGbCtD
Antipyrine—CYP2B6—Carbamazepine—epilepsy syndrome	0.00357	0.014	CbGbCtD
Antipyrine—PTGS1—Diazepam—epilepsy syndrome	0.00355	0.0139	CbGbCtD
Antipyrine—CYP2C19—Trimethadione—epilepsy syndrome	0.00336	0.0132	CbGbCtD
Antipyrine—CYP2C19—Felbamate—epilepsy syndrome	0.00336	0.0132	CbGbCtD
Antipyrine—CYP2B6—Primidone—epilepsy syndrome	0.00333	0.0131	CbGbCtD
Antipyrine—SLC22A6—Acetazolamide—epilepsy syndrome	0.00328	0.0129	CbGbCtD
Antipyrine—CYP2A6—Valproic Acid—epilepsy syndrome	0.00327	0.0128	CbGbCtD
Antipyrine—CYP2B6—Phenytoin—epilepsy syndrome	0.0032	0.0125	CbGbCtD
Antipyrine—CYP2C19—Fosphenytoin—epilepsy syndrome	0.00316	0.0124	CbGbCtD
Antipyrine—CYP2E1—Propofol—epilepsy syndrome	0.00303	0.0119	CbGbCtD
Antipyrine—CYP2B6—Propofol—epilepsy syndrome	0.00298	0.0117	CbGbCtD
Antipyrine—CYP2E1—Phenobarbital—epilepsy syndrome	0.00289	0.0113	CbGbCtD
Antipyrine—CYP2B6—Phenobarbital—epilepsy syndrome	0.00285	0.0112	CbGbCtD
Antipyrine—CYP2E1—Midazolam—epilepsy syndrome	0.00285	0.0112	CbGbCtD
Antipyrine—CYP2B6—Midazolam—epilepsy syndrome	0.00281	0.011	CbGbCtD
Antipyrine—PTGS1—Valproic Acid—epilepsy syndrome	0.0028	0.011	CbGbCtD
Antipyrine—CYP2C9—Trimethadione—epilepsy syndrome	0.00279	0.0109	CbGbCtD
Antipyrine—CYP2E1—Diazepam—epilepsy syndrome	0.00274	0.0107	CbGbCtD
Antipyrine—CYP2C19—Clobazam—epilepsy syndrome	0.00274	0.0107	CbGbCtD
Antipyrine—CYP2B6—Diazepam—epilepsy syndrome	0.0027	0.0106	CbGbCtD
Antipyrine—CYP2C8—Carbamazepine—epilepsy syndrome	0.0027	0.0106	CbGbCtD
Antipyrine—CYP2C9—Fosphenytoin—epilepsy syndrome	0.00262	0.0103	CbGbCtD
Antipyrine—CYP2C8—Primidone—epilepsy syndrome	0.00252	0.00989	CbGbCtD
Antipyrine—SLC22A6—Valproic Acid—epilepsy syndrome	0.00245	0.00962	CbGbCtD
Antipyrine—CYP2C8—Phenytoin—epilepsy syndrome	0.00242	0.0095	CbGbCtD
Antipyrine—CYP2C19—Carbamazepine—epilepsy syndrome	0.00227	0.00889	CbGbCtD
Antipyrine—CYP2C8—Propofol—epilepsy syndrome	0.00226	0.00886	CbGbCtD
Antipyrine—CYP2C8—Phenobarbital—epilepsy syndrome	0.00216	0.00847	CbGbCtD
Antipyrine—CYP2B6—Valproic Acid—epilepsy syndrome	0.00213	0.00836	CbGbCtD
Antipyrine—CYP2C19—Primidone—epilepsy syndrome	0.00212	0.0083	CbGbCtD
Antipyrine—CYP1A2—Carbamazepine—epilepsy syndrome	0.00209	0.0082	CbGbCtD
Antipyrine—CYP2C8—Diazepam—epilepsy syndrome	0.00205	0.00803	CbGbCtD
Antipyrine—CYP2C19—Phenytoin—epilepsy syndrome	0.00203	0.00797	CbGbCtD
Antipyrine—CYP1A2—Primidone—epilepsy syndrome	0.00195	0.00766	CbGbCtD
Antipyrine—TRPA1—ganglion—epilepsy syndrome	0.00191	0.161	CbGeAlD
Antipyrine—CYP2C19—Propofol—epilepsy syndrome	0.0019	0.00743	CbGbCtD
Antipyrine—CYP2C9—Carbamazepine—epilepsy syndrome	0.00188	0.00739	CbGbCtD
Antipyrine—CYP2C19—Phenobarbital—epilepsy syndrome	0.00181	0.00711	CbGbCtD
Antipyrine—CYP2C9—Primidone—epilepsy syndrome	0.00176	0.0069	CbGbCtD
Antipyrine—CYP1A2—Propofol—epilepsy syndrome	0.00175	0.00686	CbGbCtD
Antipyrine—CYP3A4—Oxcarbazepine—epilepsy syndrome	0.00175	0.00684	CbGbCtD
Antipyrine—CYP2C19—Diazepam—epilepsy syndrome	0.00172	0.00674	CbGbCtD
Antipyrine—CYP2C9—Phenytoin—epilepsy syndrome	0.00169	0.00663	CbGbCtD
Antipyrine—CYP2C19—Zonisamide—epilepsy syndrome	0.00168	0.00657	CbGbCtD
Antipyrine—CYP1A2—Phenobarbital—epilepsy syndrome	0.00167	0.00656	CbGbCtD
Antipyrine—CYP3A4—Felbamate—epilepsy syndrome	0.00162	0.00636	CbGbCtD
Antipyrine—CYP3A4—Trimethadione—epilepsy syndrome	0.00162	0.00636	CbGbCtD
Antipyrine—CYP2C8—Valproic Acid—epilepsy syndrome	0.00161	0.00633	CbGbCtD
Antipyrine—CYP1A2—Diazepam—epilepsy syndrome	0.00159	0.00621	CbGbCtD
Antipyrine—CYP2C9—Propofol—epilepsy syndrome	0.00158	0.00618	CbGbCtD
Antipyrine—CYP3A4—Fosphenytoin—epilepsy syndrome	0.00153	0.00598	CbGbCtD
Antipyrine—CYP2C9—Phenobarbital—epilepsy syndrome	0.00151	0.00591	CbGbCtD
Antipyrine—CYP2D6—Propofol—epilepsy syndrome	0.00144	0.00565	CbGbCtD
Antipyrine—CYP2C9—Diazepam—epilepsy syndrome	0.00143	0.0056	CbGbCtD
Antipyrine—CYP3A4—Clonazepam—epilepsy syndrome	0.00138	0.00541	CbGbCtD
Antipyrine—CYP2C19—Valproic Acid—epilepsy syndrome	0.00135	0.00531	CbGbCtD
Antipyrine—CYP3A4—Clobazam—epilepsy syndrome	0.00132	0.00519	CbGbCtD
Antipyrine—CYP1A2—Valproic Acid—epilepsy syndrome	0.00125	0.0049	CbGbCtD
Antipyrine—CYP2C19—Topiramate—epilepsy syndrome	0.00122	0.00479	CbGbCtD
Antipyrine—CYP2C9—Valproic Acid—epilepsy syndrome	0.00113	0.00441	CbGbCtD
Antipyrine—CYP3A4—Rufinamide—epilepsy syndrome	0.00112	0.00441	CbGbCtD
Antipyrine—CYP3A4—Carbamazepine—epilepsy syndrome	0.0011	0.0043	CbGbCtD
Antipyrine—CYP3A4—Primidone—epilepsy syndrome	0.00102	0.00401	CbGbCtD
Antipyrine—CYP3A4—Phenytoin—epilepsy syndrome	0.000983	0.00385	CbGbCtD
Antipyrine—CYP3A4—Propofol—epilepsy syndrome	0.000917	0.00359	CbGbCtD
Antipyrine—CYP3A4—Phenobarbital—epilepsy syndrome	0.000876	0.00343	CbGbCtD
Antipyrine—CYP3A4—Acetazolamide—epilepsy syndrome	0.000876	0.00343	CbGbCtD
Antipyrine—CYP3A4—Midazolam—epilepsy syndrome	0.000864	0.00339	CbGbCtD
Antipyrine—CYP3A4—Diazepam—epilepsy syndrome	0.000831	0.00326	CbGbCtD
Antipyrine—CYP3A4—Zonisamide—epilepsy syndrome	0.000811	0.00318	CbGbCtD
Antipyrine—CYP3A4—Valproic Acid—epilepsy syndrome	0.000655	0.00257	CbGbCtD
Antipyrine—CYP3A4—Topiramate—epilepsy syndrome	0.000591	0.00232	CbGbCtD
Antipyrine—TRPA1—spinal cord—epilepsy syndrome	0.000516	0.0435	CbGeAlD
Antipyrine—TRPA1—nervous system—epilepsy syndrome	0.000435	0.0366	CbGeAlD
Antipyrine—TRPA1—central nervous system—epilepsy syndrome	0.000419	0.0353	CbGeAlD
Antipyrine—PTGS1—ganglion—epilepsy syndrome	0.000278	0.0234	CbGeAlD
Antipyrine—Methsuximide—CACNA1G—epilepsy syndrome	0.000244	0.115	CrCbGaD
Antipyrine—Phensuximide—CACNA1G—epilepsy syndrome	0.000237	0.112	CrCbGaD
Antipyrine—Methsuximide—CACNA1H—epilepsy syndrome	0.00022	0.104	CrCbGaD
Antipyrine—Phensuximide—CACNA1H—epilepsy syndrome	0.000213	0.1	CrCbGaD
Antipyrine—CYP2D6—hindbrain—epilepsy syndrome	0.000173	0.0146	CbGeAlD
Antipyrine—Clobazam—SLC6A1—epilepsy syndrome	0.000169	0.0798	CrCbGaD
Antipyrine—SLC22A6—brain—epilepsy syndrome	0.000136	0.0115	CbGeAlD
Antipyrine—CYP2A6—cerebellum—epilepsy syndrome	0.000131	0.011	CbGeAlD
Antipyrine—Methylphenobarbital—GRIA2—epilepsy syndrome	0.000126	0.0596	CrCbGaD
Antipyrine—PTGS1—forebrain—epilepsy syndrome	0.000117	0.00984	CbGeAlD
Antipyrine—PTGS2—forebrain—epilepsy syndrome	0.000112	0.0094	CbGeAlD
Antipyrine—CYP2E1—telencephalon—epilepsy syndrome	0.000111	0.00939	CbGeAlD
Antipyrine—PTGS1—telencephalon—epilepsy syndrome	0.000107	0.00904	CbGeAlD
Antipyrine—CYP2A6—brain—epilepsy syndrome	0.000106	0.00897	CbGeAlD
Antipyrine—PTGS2—telencephalon—epilepsy syndrome	0.000103	0.00865	CbGeAlD
Antipyrine—CYP2D6—brainstem—epilepsy syndrome	9.94e-05	0.00838	CbGeAlD
Antipyrine—CYP2D6—forebrain—epilepsy syndrome	9.59e-05	0.00808	CbGeAlD
Antipyrine—Methylphenobarbital—CHRNA7—epilepsy syndrome	8.94e-05	0.0421	CrCbGaD
Antipyrine—CYP2D6—telencephalon—epilepsy syndrome	8.82e-05	0.00743	CbGeAlD
Antipyrine—CYP2E1—medulla oblongata—epilepsy syndrome	8.75e-05	0.00738	CbGeAlD
Antipyrine—Methylphenobarbital—GABRA5—epilepsy syndrome	8.51e-05	0.0401	CrCbGaD
Antipyrine—Methylphenobarbital—GRIK2—epilepsy syndrome	8.36e-05	0.0394	CrCbGaD
Antipyrine—Clobazam—GABRG2—epilepsy syndrome	8.14e-05	0.0384	CrCbGaD
Antipyrine—PTGS2—medulla oblongata—epilepsy syndrome	8.06e-05	0.00679	CbGeAlD
Antipyrine—CYP2E1—spinal cord—epilepsy syndrome	7.8e-05	0.00658	CbGeAlD
Antipyrine—PTGS1—spinal cord—epilepsy syndrome	7.52e-05	0.00634	CbGeAlD
Antipyrine—Aminophenazone—CYP2C19—epilepsy syndrome	7.52e-05	0.0354	CrCbGaD
Antipyrine—CYP2B6—head—epilepsy syndrome	7.39e-05	0.00623	CbGeAlD
Antipyrine—PTGS2—midbrain—epilepsy syndrome	7.37e-05	0.00621	CbGeAlD
Antipyrine—Methylphenobarbital—GABRA1—epilepsy syndrome	7.31e-05	0.0344	CrCbGaD
Antipyrine—PTGS2—spinal cord—epilepsy syndrome	7.19e-05	0.00606	CbGeAlD
Antipyrine—Methylphenobarbital—CHRNA4—epilepsy syndrome	7.15e-05	0.0337	CrCbGaD
Antipyrine—CYP2B6—nervous system—epilepsy syndrome	7.01e-05	0.00591	CbGeAlD
Antipyrine—CYP2E1—head—epilepsy syndrome	6.94e-05	0.00585	CbGeAlD
Antipyrine—CYP2B6—central nervous system—epilepsy syndrome	6.75e-05	0.00569	CbGeAlD
Antipyrine—PTGS1—head—epilepsy syndrome	6.68e-05	0.00563	CbGeAlD
Antipyrine—CYP2E1—nervous system—epilepsy syndrome	6.58e-05	0.00554	CbGeAlD
Antipyrine—PTGS2—head—epilepsy syndrome	6.39e-05	0.00538	CbGeAlD
Antipyrine—PTGS1—nervous system—epilepsy syndrome	6.33e-05	0.00534	CbGeAlD
Antipyrine—CYP2E1—central nervous system—epilepsy syndrome	6.33e-05	0.00534	CbGeAlD
Antipyrine—CYP2E1—cerebellum—epilepsy syndrome	6.19e-05	0.00522	CbGeAlD
Antipyrine—PTGS1—central nervous system—epilepsy syndrome	6.1e-05	0.00514	CbGeAlD
Antipyrine—PTGS2—nervous system—epilepsy syndrome	6.05e-05	0.0051	CbGeAlD
Antipyrine—CYP2C8—brain—epilepsy syndrome	5.97e-05	0.00503	CbGeAlD
Antipyrine—PTGS2—central nervous system—epilepsy syndrome	5.83e-05	0.00491	CbGeAlD
Antipyrine—Clobazam—GABRB2—epilepsy syndrome	5.74e-05	0.027	CrCbGaD
Antipyrine—PTGS2—cerebellum—epilepsy syndrome	5.7e-05	0.0048	CbGeAlD
Antipyrine—Clobazam—GABRA1—epilepsy syndrome	5.62e-05	0.0265	CrCbGaD
Antipyrine—Aminophenazone—CYP2D6—epilepsy syndrome	5.57e-05	0.0263	CrCbGaD
Antipyrine—Methsuximide—CYP2C19—epilepsy syndrome	5.5e-05	0.0259	CrCbGaD
Antipyrine—CYP2D6—head—epilepsy syndrome	5.49e-05	0.00463	CbGeAlD
Antipyrine—CYP2B6—brain—epilepsy syndrome	5.36e-05	0.00451	CbGeAlD
Antipyrine—Phensuximide—CYP2C19—epilepsy syndrome	5.33e-05	0.0251	CrCbGaD
Antipyrine—CYP3A4—nervous system—epilepsy syndrome	5.29e-05	0.00446	CbGeAlD
Antipyrine—CYP2D6—nervous system—epilepsy syndrome	5.21e-05	0.00439	CbGeAlD
Antipyrine—CYP3A4—central nervous system—epilepsy syndrome	5.09e-05	0.00429	CbGeAlD
Antipyrine—CYP2E1—brain—epilepsy syndrome	5.03e-05	0.00424	CbGeAlD
Antipyrine—CYP2D6—central nervous system—epilepsy syndrome	5.01e-05	0.00423	CbGeAlD
Antipyrine—CYP2D6—cerebellum—epilepsy syndrome	4.9e-05	0.00413	CbGeAlD
Antipyrine—PTGS1—brain—epilepsy syndrome	4.84e-05	0.00408	CbGeAlD
Antipyrine—PTGS2—brain—epilepsy syndrome	4.63e-05	0.0039	CbGeAlD
Antipyrine—CYP2D6—brain—epilepsy syndrome	3.98e-05	0.00335	CbGeAlD
Antipyrine—Methylphenobarbital—CYP2C19—epilepsy syndrome	3.43e-05	0.0162	CrCbGaD
Antipyrine—Clobazam—CYP2C19—epilepsy syndrome	2.64e-05	0.0125	CrCbGaD
Antipyrine—Clobazam—ABCB1—epilepsy syndrome	1.4e-05	0.00659	CrCbGaD
Antipyrine—CYP2C19—Metabolism—KCNJ11—epilepsy syndrome	2.11e-06	7.87e-05	CbGpPWpGaD
Antipyrine—PTGS2—Disease—HBEGF—epilepsy syndrome	2.1e-06	7.84e-05	CbGpPWpGaD
Antipyrine—CYP1A2—Metabolism—ADSL—epilepsy syndrome	2.08e-06	7.76e-05	CbGpPWpGaD
Antipyrine—PTGS2—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	2.07e-06	7.75e-05	CbGpPWpGaD
Antipyrine—PTGS2—Metabolism—CYP2D6—epilepsy syndrome	2.07e-06	7.72e-05	CbGpPWpGaD
Antipyrine—PTGS2—Disease—AKT3—epilepsy syndrome	2.06e-06	7.7e-05	CbGpPWpGaD
Antipyrine—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	2.04e-06	7.62e-05	CbGpPWpGaD
Antipyrine—CYP1A2—Metabolism—GLUL—epilepsy syndrome	2.04e-06	7.61e-05	CbGpPWpGaD
Antipyrine—CYP3A4—Metabolism—HSD17B4—epilepsy syndrome	2.03e-06	7.61e-05	CbGpPWpGaD
Antipyrine—PTGS2—Disease—ADAM10—epilepsy syndrome	2.01e-06	7.52e-05	CbGpPWpGaD
Antipyrine—CYP1A2—Metabolism—CACNA1D—epilepsy syndrome	2e-06	7.47e-05	CbGpPWpGaD
Antipyrine—CYP2B6—Metabolism—CYP2D6—epilepsy syndrome	1.99e-06	7.42e-05	CbGpPWpGaD
Antipyrine—CYP2C18—Metabolism—POMC—epilepsy syndrome	1.98e-06	7.4e-05	CbGpPWpGaD
Antipyrine—PTGS2—Metabolism—ADRA2A—epilepsy syndrome	1.97e-06	7.35e-05	CbGpPWpGaD
Antipyrine—CYP3A4—Metabolism—PPP1R3C—epilepsy syndrome	1.96e-06	7.35e-05	CbGpPWpGaD
Antipyrine—CYP3A4—Metabolism—GBE1—epilepsy syndrome	1.96e-06	7.35e-05	CbGpPWpGaD
Antipyrine—CYP2C19—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	1.96e-06	7.33e-05	CbGpPWpGaD
Antipyrine—PTGS2—Metabolism—BCHE—epilepsy syndrome	1.96e-06	7.32e-05	CbGpPWpGaD
Antipyrine—CYP2E1—Metabolism—CYP2D6—epilepsy syndrome	1.94e-06	7.27e-05	CbGpPWpGaD
Antipyrine—CYP2D6—Metabolism—KCNJ11—epilepsy syndrome	1.94e-06	7.24e-05	CbGpPWpGaD
Antipyrine—CYP2D6—Metabolism—CHRM3—epilepsy syndrome	1.94e-06	7.24e-05	CbGpPWpGaD
Antipyrine—PTGS1—Metabolism—HMOX1—epilepsy syndrome	1.94e-06	7.24e-05	CbGpPWpGaD
Antipyrine—CYP2C8—Metabolism—ABCG2—epilepsy syndrome	1.92e-06	7.19e-05	CbGpPWpGaD
Antipyrine—CYP2C19—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	1.92e-06	7.18e-05	CbGpPWpGaD
Antipyrine—CYP2C9—Metabolism—KCNJ11—epilepsy syndrome	1.92e-06	7.18e-05	CbGpPWpGaD
Antipyrine—CYP2C9—Metabolism—CHRM3—epilepsy syndrome	1.92e-06	7.18e-05	CbGpPWpGaD
Antipyrine—PTGS1—Metabolism—CAT—epilepsy syndrome	1.91e-06	7.14e-05	CbGpPWpGaD
Antipyrine—CYP2B6—Metabolism—ADRA2A—epilepsy syndrome	1.89e-06	7.07e-05	CbGpPWpGaD
Antipyrine—CYP2B6—Metabolism—BCHE—epilepsy syndrome	1.88e-06	7.04e-05	CbGpPWpGaD
Antipyrine—PTGS2—Disease—CDC42—epilepsy syndrome	1.88e-06	7.02e-05	CbGpPWpGaD
Antipyrine—CYP2C8—Metabolism—CYP2C19—epilepsy syndrome	1.87e-06	7.01e-05	CbGpPWpGaD
Antipyrine—CYP1A2—Metabolism—TXNRD1—epilepsy syndrome	1.87e-06	6.99e-05	CbGpPWpGaD
Antipyrine—PTGS2—Metabolism—SLC2A1—epilepsy syndrome	1.87e-06	6.98e-05	CbGpPWpGaD
Antipyrine—CYP2C8—Metabolism—CYP11A1—epilepsy syndrome	1.86e-06	6.96e-05	CbGpPWpGaD
Antipyrine—PTGS1—Metabolism—ABCB1—epilepsy syndrome	1.86e-06	6.95e-05	CbGpPWpGaD
Antipyrine—CYP2E1—Metabolism—ADRA2A—epilepsy syndrome	1.85e-06	6.92e-05	CbGpPWpGaD
Antipyrine—CYP2C8—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	1.85e-06	6.91e-05	CbGpPWpGaD
Antipyrine—PTGS2—Metabolism—PLCB1—epilepsy syndrome	1.85e-06	6.91e-05	CbGpPWpGaD
Antipyrine—CYP3A4—Metabolism—ASAH1—epilepsy syndrome	1.85e-06	6.91e-05	CbGpPWpGaD
Antipyrine—CYP2E1—Metabolism—BCHE—epilepsy syndrome	1.84e-06	6.89e-05	CbGpPWpGaD
Antipyrine—PTGS2—Metabolism—TH—epilepsy syndrome	1.84e-06	6.88e-05	CbGpPWpGaD
Antipyrine—CYP2A6—Metabolism—HMOX1—epilepsy syndrome	1.83e-06	6.84e-05	CbGpPWpGaD
Antipyrine—CYP1A2—Metabolism—AQP1—epilepsy syndrome	1.81e-06	6.78e-05	CbGpPWpGaD
Antipyrine—CYP2A6—Metabolism—CAT—epilepsy syndrome	1.81e-06	6.75e-05	CbGpPWpGaD
Antipyrine—CYP2C18—Metabolism—ALB—epilepsy syndrome	1.8e-06	6.74e-05	CbGpPWpGaD
Antipyrine—CYP3A4—Metabolism—STXBP1—epilepsy syndrome	1.8e-06	6.72e-05	CbGpPWpGaD
Antipyrine—CYP2B6—Metabolism—SLC2A1—epilepsy syndrome	1.8e-06	6.71e-05	CbGpPWpGaD
Antipyrine—CYP2C9—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	1.79e-06	6.68e-05	CbGpPWpGaD
Antipyrine—CYP2B6—Metabolism—PLCB1—epilepsy syndrome	1.78e-06	6.64e-05	CbGpPWpGaD
Antipyrine—CYP2B6—Metabolism—TH—epilepsy syndrome	1.77e-06	6.62e-05	CbGpPWpGaD
Antipyrine—CYP2E1—Metabolism—SLC2A1—epilepsy syndrome	1.76e-06	6.58e-05	CbGpPWpGaD
Antipyrine—CYP2A6—Metabolism—ABCB1—epilepsy syndrome	1.76e-06	6.57e-05	CbGpPWpGaD
Antipyrine—CYP2C9—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	1.75e-06	6.55e-05	CbGpPWpGaD
Antipyrine—CYP3A4—Metabolism—NT5E—epilepsy syndrome	1.75e-06	6.55e-05	CbGpPWpGaD
Antipyrine—CYP3A4—Metabolism—ALAD—epilepsy syndrome	1.75e-06	6.55e-05	CbGpPWpGaD
Antipyrine—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	1.74e-06	6.51e-05	CbGpPWpGaD
Antipyrine—CYP2E1—Metabolism—PLCB1—epilepsy syndrome	1.74e-06	6.5e-05	CbGpPWpGaD
Antipyrine—CYP2E1—Metabolism—TH—epilepsy syndrome	1.73e-06	6.48e-05	CbGpPWpGaD
Antipyrine—PTGS1—Metabolism—GPX1—epilepsy syndrome	1.73e-06	6.46e-05	CbGpPWpGaD
Antipyrine—PTGS2—Disease—HES1—epilepsy syndrome	1.72e-06	6.43e-05	CbGpPWpGaD
Antipyrine—CYP2C19—Metabolism—ABCG2—epilepsy syndrome	1.72e-06	6.42e-05	CbGpPWpGaD
Antipyrine—CYP2C8—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	1.69e-06	6.3e-05	CbGpPWpGaD
Antipyrine—CYP2C8—Metabolism—CYP2D6—epilepsy syndrome	1.68e-06	6.28e-05	CbGpPWpGaD
Antipyrine—PTGS2—Disease—FYN—epilepsy syndrome	1.67e-06	6.25e-05	CbGpPWpGaD
Antipyrine—CYP3A4—Metabolism—ALDH7A1—epilepsy syndrome	1.67e-06	6.25e-05	CbGpPWpGaD
Antipyrine—CYP3A4—Metabolism—CACNA1A—epilepsy syndrome	1.67e-06	6.25e-05	CbGpPWpGaD
Antipyrine—PTGS2—Disease—H2AFX—epilepsy syndrome	1.67e-06	6.23e-05	CbGpPWpGaD
Antipyrine—CYP2C19—Metabolism—CYP11A1—epilepsy syndrome	1.66e-06	6.22e-05	CbGpPWpGaD
Antipyrine—CYP2C19—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	1.65e-06	6.17e-05	CbGpPWpGaD
Antipyrine—CYP1A2—Metabolism—CHRM3—epilepsy syndrome	1.64e-06	6.13e-05	CbGpPWpGaD
Antipyrine—CYP1A2—Metabolism—KCNJ11—epilepsy syndrome	1.64e-06	6.13e-05	CbGpPWpGaD
Antipyrine—CYP3A4—Metabolism—ST3GAL3—epilepsy syndrome	1.63e-06	6.11e-05	CbGpPWpGaD
Antipyrine—CYP2A6—Metabolism—GPX1—epilepsy syndrome	1.63e-06	6.11e-05	CbGpPWpGaD
Antipyrine—PTGS2—Disease—YWHAZ—epilepsy syndrome	1.61e-06	6.01e-05	CbGpPWpGaD
Antipyrine—CYP3A4—Metabolism—ADSL—epilepsy syndrome	1.6e-06	5.99e-05	CbGpPWpGaD
Antipyrine—CYP2C8—Metabolism—ADRA2A—epilepsy syndrome	1.6e-06	5.98e-05	CbGpPWpGaD
Antipyrine—CYP2C8—Metabolism—BCHE—epilepsy syndrome	1.59e-06	5.96e-05	CbGpPWpGaD
Antipyrine—CYP2D6—Metabolism—ABCG2—epilepsy syndrome	1.58e-06	5.9e-05	CbGpPWpGaD
Antipyrine—CYP2C18—Metabolism—PTGS2—epilepsy syndrome	1.58e-06	5.9e-05	CbGpPWpGaD
Antipyrine—CYP3A4—Metabolism—GLUL—epilepsy syndrome	1.57e-06	5.87e-05	CbGpPWpGaD
Antipyrine—CYP2C9—Metabolism—ABCG2—epilepsy syndrome	1.57e-06	5.85e-05	CbGpPWpGaD
Antipyrine—PTGS2—Disease—CCR5—epilepsy syndrome	1.55e-06	5.78e-05	CbGpPWpGaD
Antipyrine—CYP3A4—Metabolism—CACNA1D—epilepsy syndrome	1.54e-06	5.76e-05	CbGpPWpGaD
Antipyrine—CYP2D6—Metabolism—CYP2C19—epilepsy syndrome	1.54e-06	5.75e-05	CbGpPWpGaD
Antipyrine—PTGS2—Metabolism—HMOX1—epilepsy syndrome	1.54e-06	5.75e-05	CbGpPWpGaD
Antipyrine—CYP2D6—Metabolism—CYP11A1—epilepsy syndrome	1.53e-06	5.72e-05	CbGpPWpGaD
Antipyrine—CYP1A2—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	1.53e-06	5.71e-05	CbGpPWpGaD
Antipyrine—CYP2C9—Metabolism—CYP2C19—epilepsy syndrome	1.53e-06	5.7e-05	CbGpPWpGaD
Antipyrine—CYP2C8—Metabolism—SLC2A1—epilepsy syndrome	1.52e-06	5.68e-05	CbGpPWpGaD
Antipyrine—PTGS2—Metabolism—CAT—epilepsy syndrome	1.52e-06	5.67e-05	CbGpPWpGaD
Antipyrine—CYP2C9—Metabolism—CYP11A1—epilepsy syndrome	1.52e-06	5.67e-05	CbGpPWpGaD
Antipyrine—PTGS1—Metabolism—AGT—epilepsy syndrome	1.51e-06	5.66e-05	CbGpPWpGaD
Antipyrine—CYP2C9—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	1.5e-06	5.63e-05	CbGpPWpGaD
Antipyrine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	1.5e-06	5.63e-05	CbGpPWpGaD
Antipyrine—CYP2C8—Metabolism—PLCB1—epilepsy syndrome	1.5e-06	5.62e-05	CbGpPWpGaD
Antipyrine—CYP2C19—Metabolism—CYP2D6—epilepsy syndrome	1.5e-06	5.61e-05	CbGpPWpGaD
Antipyrine—CYP2C8—Metabolism—TH—epilepsy syndrome	1.5e-06	5.6e-05	CbGpPWpGaD
Antipyrine—CYP1A2—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	1.5e-06	5.6e-05	CbGpPWpGaD
Antipyrine—PTGS1—Metabolism—APOE—epilepsy syndrome	1.48e-06	5.55e-05	CbGpPWpGaD
Antipyrine—CYP2B6—Metabolism—HMOX1—epilepsy syndrome	1.48e-06	5.52e-05	CbGpPWpGaD
Antipyrine—PTGS2—Metabolism—ABCB1—epilepsy syndrome	1.47e-06	5.51e-05	CbGpPWpGaD
Antipyrine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	1.47e-06	5.51e-05	CbGpPWpGaD
Antipyrine—CYP2B6—Metabolism—CAT—epilepsy syndrome	1.46e-06	5.45e-05	CbGpPWpGaD
Antipyrine—CYP2E1—Metabolism—HMOX1—epilepsy syndrome	1.45e-06	5.41e-05	CbGpPWpGaD
Antipyrine—CYP3A4—Metabolism—TXNRD1—epilepsy syndrome	1.44e-06	5.39e-05	CbGpPWpGaD
Antipyrine—PTGS2—Disease—TSC2—epilepsy syndrome	1.44e-06	5.37e-05	CbGpPWpGaD
Antipyrine—CYP2A6—Metabolism—AGT—epilepsy syndrome	1.43e-06	5.35e-05	CbGpPWpGaD
Antipyrine—CYP2C19—Metabolism—ADRA2A—epilepsy syndrome	1.43e-06	5.34e-05	CbGpPWpGaD
Antipyrine—CYP2E1—Metabolism—CAT—epilepsy syndrome	1.43e-06	5.34e-05	CbGpPWpGaD
Antipyrine—CYP2C19—Metabolism—BCHE—epilepsy syndrome	1.42e-06	5.32e-05	CbGpPWpGaD
Antipyrine—CYP2B6—Metabolism—ABCB1—epilepsy syndrome	1.42e-06	5.3e-05	CbGpPWpGaD
Antipyrine—PTGS2—Disease—APOE—epilepsy syndrome	1.41e-06	5.26e-05	CbGpPWpGaD
Antipyrine—CYP2A6—Metabolism—APOE—epilepsy syndrome	1.4e-06	5.25e-05	CbGpPWpGaD
Antipyrine—CYP3A4—Metabolism—AQP1—epilepsy syndrome	1.4e-06	5.23e-05	CbGpPWpGaD
Antipyrine—CYP2E1—Metabolism—ABCB1—epilepsy syndrome	1.39e-06	5.19e-05	CbGpPWpGaD
Antipyrine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	1.37e-06	5.13e-05	CbGpPWpGaD
Antipyrine—PTGS2—Metabolism—GPX1—epilepsy syndrome	1.37e-06	5.13e-05	CbGpPWpGaD
Antipyrine—CYP2C9—Metabolism—CYP2D6—epilepsy syndrome	1.37e-06	5.11e-05	CbGpPWpGaD
Antipyrine—CYP2C19—Metabolism—SLC2A1—epilepsy syndrome	1.36e-06	5.07e-05	CbGpPWpGaD
Antipyrine—CYP2C19—Metabolism—PLCB1—epilepsy syndrome	1.34e-06	5.02e-05	CbGpPWpGaD
Antipyrine—CYP1A2—Metabolism—ABCG2—epilepsy syndrome	1.34e-06	5e-05	CbGpPWpGaD
Antipyrine—CYP2C19—Metabolism—TH—epilepsy syndrome	1.34e-06	5e-05	CbGpPWpGaD
Antipyrine—PTGS2—Disease—IL6ST—epilepsy syndrome	1.32e-06	4.94e-05	CbGpPWpGaD
Antipyrine—CYP2B6—Metabolism—GPX1—epilepsy syndrome	1.32e-06	4.93e-05	CbGpPWpGaD
Antipyrine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	1.32e-06	4.92e-05	CbGpPWpGaD
Antipyrine—CYP2D6—Metabolism—ADRA2A—epilepsy syndrome	1.31e-06	4.91e-05	CbGpPWpGaD
Antipyrine—PTGS2—Disease—NOS2—epilepsy syndrome	1.31e-06	4.9e-05	CbGpPWpGaD
Antipyrine—CYP2D6—Metabolism—BCHE—epilepsy syndrome	1.31e-06	4.89e-05	CbGpPWpGaD
Antipyrine—CYP1A2—Metabolism—CYP2C19—epilepsy syndrome	1.3e-06	4.87e-05	CbGpPWpGaD
Antipyrine—CYP2C9—Metabolism—ADRA2A—epilepsy syndrome	1.3e-06	4.87e-05	CbGpPWpGaD
Antipyrine—CYP2C9—Metabolism—BCHE—epilepsy syndrome	1.3e-06	4.85e-05	CbGpPWpGaD
Antipyrine—CYP1A2—Metabolism—CYP11A1—epilepsy syndrome	1.3e-06	4.84e-05	CbGpPWpGaD
Antipyrine—CYP2E1—Metabolism—GPX1—epilepsy syndrome	1.29e-06	4.83e-05	CbGpPWpGaD
Antipyrine—CYP1A2—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	1.29e-06	4.81e-05	CbGpPWpGaD
Antipyrine—PTGS1—Metabolism—POMC—epilepsy syndrome	1.27e-06	4.77e-05	CbGpPWpGaD
Antipyrine—CYP3A4—Metabolism—KCNJ11—epilepsy syndrome	1.27e-06	4.73e-05	CbGpPWpGaD
Antipyrine—CYP3A4—Metabolism—CHRM3—epilepsy syndrome	1.27e-06	4.73e-05	CbGpPWpGaD
Antipyrine—CYP2C8—Metabolism—HMOX1—epilepsy syndrome	1.25e-06	4.67e-05	CbGpPWpGaD
Antipyrine—CYP2D6—Metabolism—SLC2A1—epilepsy syndrome	1.25e-06	4.67e-05	CbGpPWpGaD
Antipyrine—CYP2C9—Metabolism—SLC2A1—epilepsy syndrome	1.24e-06	4.63e-05	CbGpPWpGaD
Antipyrine—CYP2D6—Metabolism—PLCB1—epilepsy syndrome	1.23e-06	4.61e-05	CbGpPWpGaD
Antipyrine—CYP2C8—Metabolism—CAT—epilepsy syndrome	1.23e-06	4.61e-05	CbGpPWpGaD
Antipyrine—CYP2D6—Metabolism—TH—epilepsy syndrome	1.23e-06	4.6e-05	CbGpPWpGaD
Antipyrine—CYP2C9—Metabolism—PLCB1—epilepsy syndrome	1.22e-06	4.57e-05	CbGpPWpGaD
Antipyrine—CYP2C9—Metabolism—TH—epilepsy syndrome	1.22e-06	4.56e-05	CbGpPWpGaD
Antipyrine—CYP2A6—Metabolism—POMC—epilepsy syndrome	1.21e-06	4.51e-05	CbGpPWpGaD
Antipyrine—PTGS2—Metabolism—AGT—epilepsy syndrome	1.2e-06	4.5e-05	CbGpPWpGaD
Antipyrine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	1.2e-06	4.49e-05	CbGpPWpGaD
Antipyrine—CYP2C8—Metabolism—ABCB1—epilepsy syndrome	1.2e-06	4.49e-05	CbGpPWpGaD
Antipyrine—PTGS2—Metabolism—APOE—epilepsy syndrome	1.18e-06	4.4e-05	CbGpPWpGaD
Antipyrine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	1.17e-06	4.38e-05	CbGpPWpGaD
Antipyrine—CYP1A2—Metabolism—CYP2D6—epilepsy syndrome	1.17e-06	4.37e-05	CbGpPWpGaD
Antipyrine—PTGS1—Metabolism—ALB—epilepsy syndrome	1.16e-06	4.35e-05	CbGpPWpGaD
Antipyrine—CYP2B6—Metabolism—AGT—epilepsy syndrome	1.16e-06	4.32e-05	CbGpPWpGaD
Antipyrine—CYP2B6—Metabolism—APOE—epilepsy syndrome	1.13e-06	4.23e-05	CbGpPWpGaD
Antipyrine—CYP2E1—Metabolism—AGT—epilepsy syndrome	1.13e-06	4.23e-05	CbGpPWpGaD
Antipyrine—CYP2C19—Metabolism—HMOX1—epilepsy syndrome	1.12e-06	4.17e-05	CbGpPWpGaD
Antipyrine—CYP2C8—Metabolism—GPX1—epilepsy syndrome	1.12e-06	4.17e-05	CbGpPWpGaD
Antipyrine—CYP1A2—Metabolism—ADRA2A—epilepsy syndrome	1.11e-06	4.16e-05	CbGpPWpGaD
Antipyrine—CYP2E1—Metabolism—APOE—epilepsy syndrome	1.11e-06	4.15e-05	CbGpPWpGaD
Antipyrine—CYP1A2—Metabolism—BCHE—epilepsy syndrome	1.11e-06	4.14e-05	CbGpPWpGaD
Antipyrine—CYP2C19—Metabolism—CAT—epilepsy syndrome	1.1e-06	4.12e-05	CbGpPWpGaD
Antipyrine—CYP2A6—Metabolism—ALB—epilepsy syndrome	1.1e-06	4.11e-05	CbGpPWpGaD
Antipyrine—CYP2C19—Metabolism—ABCB1—epilepsy syndrome	1.07e-06	4e-05	CbGpPWpGaD
Antipyrine—PTGS2—Disease—FGF2—epilepsy syndrome	1.07e-06	4e-05	CbGpPWpGaD
Antipyrine—CYP1A2—Metabolism—SLC2A1—epilepsy syndrome	1.06e-06	3.95e-05	CbGpPWpGaD
Antipyrine—CYP1A2—Metabolism—PLCB1—epilepsy syndrome	1.05e-06	3.91e-05	CbGpPWpGaD
Antipyrine—CYP1A2—Metabolism—TH—epilepsy syndrome	1.04e-06	3.9e-05	CbGpPWpGaD
Antipyrine—CYP3A4—Metabolism—ABCG2—epilepsy syndrome	1.03e-06	3.86e-05	CbGpPWpGaD
Antipyrine—CYP2D6—Metabolism—HMOX1—epilepsy syndrome	1.03e-06	3.84e-05	CbGpPWpGaD
Antipyrine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	1.03e-06	3.83e-05	CbGpPWpGaD
Antipyrine—CYP2C9—Metabolism—HMOX1—epilepsy syndrome	1.02e-06	3.8e-05	CbGpPWpGaD
Antipyrine—PTGS1—Metabolism—PTGS2—epilepsy syndrome	1.02e-06	3.8e-05	CbGpPWpGaD
Antipyrine—CYP2D6—Metabolism—CAT—epilepsy syndrome	1.01e-06	3.79e-05	CbGpPWpGaD
Antipyrine—PTGS2—Metabolism—POMC—epilepsy syndrome	1.01e-06	3.78e-05	CbGpPWpGaD
Antipyrine—CYP3A4—Metabolism—CYP2C19—epilepsy syndrome	1.01e-06	3.76e-05	CbGpPWpGaD
Antipyrine—CYP2C9—Metabolism—CAT—epilepsy syndrome	1e-06	3.75e-05	CbGpPWpGaD
Antipyrine—CYP3A4—Metabolism—CYP11A1—epilepsy syndrome	1e-06	3.74e-05	CbGpPWpGaD
Antipyrine—CYP2C19—Metabolism—GPX1—epilepsy syndrome	9.96e-07	3.72e-05	CbGpPWpGaD
Antipyrine—CYP2D6—Metabolism—ABCB1—epilepsy syndrome	9.85e-07	3.68e-05	CbGpPWpGaD
Antipyrine—CYP2C8—Metabolism—AGT—epilepsy syndrome	9.78e-07	3.66e-05	CbGpPWpGaD
Antipyrine—CYP2C9—Metabolism—ABCB1—epilepsy syndrome	9.77e-07	3.65e-05	CbGpPWpGaD
Antipyrine—PTGS2—Disease—MTOR—epilepsy syndrome	9.73e-07	3.64e-05	CbGpPWpGaD
Antipyrine—CYP2B6—Metabolism—POMC—epilepsy syndrome	9.73e-07	3.64e-05	CbGpPWpGaD
Antipyrine—CYP2A6—Metabolism—PTGS2—epilepsy syndrome	9.62e-07	3.6e-05	CbGpPWpGaD
Antipyrine—CYP2C8—Metabolism—APOE—epilepsy syndrome	9.59e-07	3.58e-05	CbGpPWpGaD
Antipyrine—CYP2E1—Metabolism—POMC—epilepsy syndrome	9.53e-07	3.56e-05	CbGpPWpGaD
Antipyrine—PTGS2—Metabolism—ALB—epilepsy syndrome	9.23e-07	3.45e-05	CbGpPWpGaD
Antipyrine—CYP2D6—Metabolism—GPX1—epilepsy syndrome	9.16e-07	3.42e-05	CbGpPWpGaD
Antipyrine—CYP2C9—Metabolism—GPX1—epilepsy syndrome	9.08e-07	3.39e-05	CbGpPWpGaD
Antipyrine—CYP3A4—Metabolism—CYP2D6—epilepsy syndrome	9.02e-07	3.37e-05	CbGpPWpGaD
Antipyrine—CYP2B6—Metabolism—ALB—epilepsy syndrome	8.87e-07	3.32e-05	CbGpPWpGaD
Antipyrine—CYP2C19—Metabolism—AGT—epilepsy syndrome	8.73e-07	3.26e-05	CbGpPWpGaD
Antipyrine—CYP1A2—Metabolism—HMOX1—epilepsy syndrome	8.7e-07	3.25e-05	CbGpPWpGaD
Antipyrine—CYP2E1—Metabolism—ALB—epilepsy syndrome	8.69e-07	3.25e-05	CbGpPWpGaD
Antipyrine—CYP3A4—Metabolism—ADRA2A—epilepsy syndrome	8.59e-07	3.21e-05	CbGpPWpGaD
Antipyrine—CYP1A2—Metabolism—CAT—epilepsy syndrome	8.58e-07	3.21e-05	CbGpPWpGaD
Antipyrine—CYP2C19—Metabolism—APOE—epilepsy syndrome	8.56e-07	3.2e-05	CbGpPWpGaD
Antipyrine—CYP3A4—Metabolism—BCHE—epilepsy syndrome	8.55e-07	3.2e-05	CbGpPWpGaD
Antipyrine—CYP1A2—Metabolism—ABCB1—epilepsy syndrome	8.35e-07	3.12e-05	CbGpPWpGaD
Antipyrine—CYP2C8—Metabolism—POMC—epilepsy syndrome	8.23e-07	3.08e-05	CbGpPWpGaD
Antipyrine—CYP3A4—Metabolism—SLC2A1—epilepsy syndrome	8.16e-07	3.05e-05	CbGpPWpGaD
Antipyrine—CYP3A4—Metabolism—PLCB1—epilepsy syndrome	8.07e-07	3.02e-05	CbGpPWpGaD
Antipyrine—CYP3A4—Metabolism—TH—epilepsy syndrome	8.04e-07	3.01e-05	CbGpPWpGaD
Antipyrine—CYP2D6—Metabolism—AGT—epilepsy syndrome	8.03e-07	3e-05	CbGpPWpGaD
Antipyrine—CYP2C9—Metabolism—AGT—epilepsy syndrome	7.96e-07	2.98e-05	CbGpPWpGaD
Antipyrine—CYP2C18—Metabolism—AKT1—epilepsy syndrome	7.93e-07	2.97e-05	CbGpPWpGaD
Antipyrine—CYP2D6—Metabolism—APOE—epilepsy syndrome	7.87e-07	2.94e-05	CbGpPWpGaD
Antipyrine—CYP2C9—Metabolism—APOE—epilepsy syndrome	7.8e-07	2.92e-05	CbGpPWpGaD
Antipyrine—PTGS2—Disease—SRC—epilepsy syndrome	7.8e-07	2.91e-05	CbGpPWpGaD
Antipyrine—CYP1A2—Metabolism—GPX1—epilepsy syndrome	7.76e-07	2.9e-05	CbGpPWpGaD
Antipyrine—CYP2B6—Metabolism—PTGS2—epilepsy syndrome	7.76e-07	2.9e-05	CbGpPWpGaD
Antipyrine—CYP2E1—Metabolism—PTGS2—epilepsy syndrome	7.6e-07	2.84e-05	CbGpPWpGaD
Antipyrine—CYP2C8—Metabolism—ALB—epilepsy syndrome	7.51e-07	2.81e-05	CbGpPWpGaD
Antipyrine—CYP2C19—Metabolism—POMC—epilepsy syndrome	7.35e-07	2.75e-05	CbGpPWpGaD
Antipyrine—CYP1A2—Metabolism—AGT—epilepsy syndrome	6.8e-07	2.54e-05	CbGpPWpGaD
Antipyrine—CYP2D6—Metabolism—POMC—epilepsy syndrome	6.76e-07	2.53e-05	CbGpPWpGaD
Antipyrine—CYP3A4—Metabolism—HMOX1—epilepsy syndrome	6.71e-07	2.51e-05	CbGpPWpGaD
Antipyrine—CYP2C9—Metabolism—POMC—epilepsy syndrome	6.7e-07	2.51e-05	CbGpPWpGaD
Antipyrine—CYP2C19—Metabolism—ALB—epilepsy syndrome	6.7e-07	2.51e-05	CbGpPWpGaD
Antipyrine—CYP1A2—Metabolism—APOE—epilepsy syndrome	6.67e-07	2.49e-05	CbGpPWpGaD
Antipyrine—CYP3A4—Metabolism—CAT—epilepsy syndrome	6.62e-07	2.48e-05	CbGpPWpGaD
Antipyrine—CYP2C8—Metabolism—PTGS2—epilepsy syndrome	6.57e-07	2.46e-05	CbGpPWpGaD
Antipyrine—CYP3A4—Metabolism—ABCB1—epilepsy syndrome	6.44e-07	2.41e-05	CbGpPWpGaD
Antipyrine—CYP2D6—Metabolism—ALB—epilepsy syndrome	6.16e-07	2.3e-05	CbGpPWpGaD
Antipyrine—CYP2C9—Metabolism—ALB—epilepsy syndrome	6.11e-07	2.28e-05	CbGpPWpGaD
Antipyrine—CYP3A4—Metabolism—GPX1—epilepsy syndrome	5.99e-07	2.24e-05	CbGpPWpGaD
Antipyrine—CYP2C19—Metabolism—PTGS2—epilepsy syndrome	5.86e-07	2.19e-05	CbGpPWpGaD
Antipyrine—CYP1A2—Metabolism—POMC—epilepsy syndrome	5.73e-07	2.14e-05	CbGpPWpGaD
Antipyrine—CYP2D6—Metabolism—PTGS2—epilepsy syndrome	5.39e-07	2.02e-05	CbGpPWpGaD
Antipyrine—CYP2C9—Metabolism—PTGS2—epilepsy syndrome	5.35e-07	2e-05	CbGpPWpGaD
Antipyrine—CYP3A4—Metabolism—AGT—epilepsy syndrome	5.25e-07	1.96e-05	CbGpPWpGaD
Antipyrine—CYP1A2—Metabolism—ALB—epilepsy syndrome	5.22e-07	1.95e-05	CbGpPWpGaD
Antipyrine—CYP3A4—Metabolism—APOE—epilepsy syndrome	5.15e-07	1.92e-05	CbGpPWpGaD
Antipyrine—PTGS1—Metabolism—AKT1—epilepsy syndrome	5.11e-07	1.91e-05	CbGpPWpGaD
Antipyrine—PTGS2—Disease—AKT1—epilepsy syndrome	4.84e-07	1.81e-05	CbGpPWpGaD
Antipyrine—CYP2A6—Metabolism—AKT1—epilepsy syndrome	4.83e-07	1.81e-05	CbGpPWpGaD
Antipyrine—CYP1A2—Metabolism—PTGS2—epilepsy syndrome	4.57e-07	1.71e-05	CbGpPWpGaD
Antipyrine—CYP3A4—Metabolism—POMC—epilepsy syndrome	4.42e-07	1.65e-05	CbGpPWpGaD
Antipyrine—PTGS2—Metabolism—AKT1—epilepsy syndrome	4.06e-07	1.52e-05	CbGpPWpGaD
Antipyrine—CYP3A4—Metabolism—ALB—epilepsy syndrome	4.03e-07	1.51e-05	CbGpPWpGaD
Antipyrine—CYP2B6—Metabolism—AKT1—epilepsy syndrome	3.9e-07	1.46e-05	CbGpPWpGaD
Antipyrine—CYP2E1—Metabolism—AKT1—epilepsy syndrome	3.82e-07	1.43e-05	CbGpPWpGaD
Antipyrine—CYP3A4—Metabolism—PTGS2—epilepsy syndrome	3.53e-07	1.32e-05	CbGpPWpGaD
Antipyrine—CYP2C8—Metabolism—AKT1—epilepsy syndrome	3.3e-07	1.23e-05	CbGpPWpGaD
Antipyrine—CYP2C19—Metabolism—AKT1—epilepsy syndrome	2.95e-07	1.1e-05	CbGpPWpGaD
Antipyrine—CYP2D6—Metabolism—AKT1—epilepsy syndrome	2.71e-07	1.01e-05	CbGpPWpGaD
Antipyrine—CYP2C9—Metabolism—AKT1—epilepsy syndrome	2.69e-07	1e-05	CbGpPWpGaD
Antipyrine—CYP1A2—Metabolism—AKT1—epilepsy syndrome	2.3e-07	8.58e-06	CbGpPWpGaD
Antipyrine—CYP3A4—Metabolism—AKT1—epilepsy syndrome	1.77e-07	6.62e-06	CbGpPWpGaD
